Revium Rx (RVRC) Notes Payables (2024 - 2026)

Revium Rx has disclosed Notes Payables across 3 years of filings, most recently posting $1000.0 for Q2 2026.

• In Q2 2026, Notes Payables changed N/A year-over-year to $1000.0; the TTM figure through Jun 2026 stood at $1000.0 (changed N/A YoY), while the FY2025 annual figure was $1000.0, down 99.54% from the prior year.
• Notes Payables came in at $1000.0 for Q2 2026 at Revium Rx, roughly flat from $1000.0 in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $217000.0 in Q4 2024 to a low of $1000.0 in Q4 2025.
• Average Notes Payables over 3 years is $73000.0, with a median of $1000.0 recorded in 2025.
• The largest YoY upside for Notes Payables was 99.54% in 2025 against a maximum downside of 99.54% in 2025.
• Over 3 years, Notes Payables stood at $217000.0 in 2024, then slumped by 99.54% to $1000.0 in 2025, then changed by 0.0% to $1000.0 in 2026.
• Per Business Quant data, the three most recent Notes Payables figures were $1000.0 in Q2 2026, $1000.0 in Q4 2025, and $217000.0 in Q4 2024.